Fidelity FHLC Outperforms iShares IXJ With Lower Fees and Stronger Returns
Fidelity's FHLC beats iShares' IXJ in long-term performance and cost efficiency, making it the preferred healthcare sector play for investors prioritizing returns…
Fidelity's FHLC beats iShares' IXJ in long-term performance and cost efficiency, making it the preferred healthcare sector play for investors prioritizing returns…
West Pharmaceutical Services leverages high-value biologic components and strong demand for self-injection platforms to outperform the broader market, securing a consensus Strong…
Cardinal Health shares remain supported by a 'Strong Buy' consensus and a $5 billion buyback expansion, even as the stock navigates recent…
Pediatrix posted strong adjusted earnings, but growth relies heavily on pricing and share repurchases as core patient volumes continue to slide.
Healthcare stocks like LLY, UNH, and JNJ provide tailored investment profiles for different age groups, balancing high-growth obesity drug pipelines with defensive…
Tenet Healthcare shares dropped 2.3% premarket as director Richard Mark offloaded 10,000 shares in a transaction valued at $2.63 million, leaving him…
Investors looking for value outside the tech-heavy rally may find opportunities in TransMedics and SoFi, as both stocks trade at significant discounts…
Eli Lilly stock gains 1.6% as Berenberg upgrades the pharmaceutical giant to Buy, citing strong growth prospects for its obesity and diabetes…
CVS Health trades at an 11x forward P/E despite a strong Q2 earnings beat and raised 2026 guidance, leaving significant upside potential…
Congressional filings reveal new positions in Boston Scientific and Accenture, as BSX bulls argue the stock's 50% drop ignores strong core growth…
JNJ stock gains 1.3% as reports emerge of a potential $20 billion sale of its orthopedics unit to Apollo Global Management, a…
Small business employees over 65 must enroll in Medicare Part B to avoid massive out-of-pocket costs, as plans at firms with under…